Aditxt Subsidiary Pearsanta Receives IRB Approval to Initiate Clinical Study of Blood-Based Diagnostic for Endometriosis with Patient Enrollment Planned to Begin in May 2025
1. Aditxt's subsidiary, Pearsanta, received IRB approval for endometriosis test study. 2. The Mitomic® Endometriosis Test aims to improve early detection of endometriosis.